IP Library Patent Application 12981260
Patent Application
App. No. 12/981,260

METHODS FOR USING A THREE-DIMENSIONAL STROMAL TISSUE TO PROMOTE ANGIOGENESIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/981,260
Abstract

The present invention relates to a method for promoting blood vessel formation in tissues and organs. In particular, the method relates to implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues. The three-dimensional stromal tissue of the present invention may be used in a variety of applications including, but not limited to, promoting repair of and regeneration of damaged cardiac muscle, promoting vascularization and healing during cardiac surgery, promoting blood vessel formation at anastomosis sites, and promoting vascularization and repair of damaged skeletal muscle, smooth muscle or connective tissue.

Claims (18)

1 - 41 . (canceled)

42 . A method for effecting angiogenesis in ischemic heart tissue of a subject comprising

contacting ischemic heart tissue of said subject with a three-dimensional stromal tissue comprising fibroblasts and connective tissue proteins naturally secreted by the fibroblasts, said cells being attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the fibroblasts;

wherein said stromal tissue is capable of effecting angiogenesis in ischemic heart tissue.

43 . The method of claim 42 wherein the framework is composed of a biodegradable material.

44 . The method of claim 43 wherein the biodegradable material is polyglycolic acid, catgut sutures, cellulose, gelatin, collagen, or dextran.

45 . The method of claim 42 wherein the framework is a mesh.

46 . The method of claim 42 wherein the stromal tissue is obtained directly from a fresh culture.

47 . The method of claim 42 wherein the stromal tissue has been cryopreserved.

48 . The method of claim 42 further comprising adhering the stromal tissue to the ischemic heart tissue by natural cellular attachment.

49 . The method of claim 42 further comprising attaching the stromal tissue to the ischemic heart tissue by means of a biodegradable or non-biodegradable suture, a biologic glue, a synthetic glue, a laser dye, or a hydrogel.

50 . The method of claim 42 wherein the ischemic tissue is of the heart epicardium.

51 . A method for effecting vascularization in damaged cardiac tissue of a subject, comprising

attaching a three-dimensional stromal tissue to an epicardial or myocardial surface near a damaged region of cardiac tissue of a subject,

wherein the three-dimensional stromal tissue comprises fibroblasts and connective tissue proteins naturally secreted by the fibroblasts, said cells being attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the fibroblasts; and

wherein said stromal tissue is capable of effecting vascularization in damaged cardiac tissue.

52 . The method of claim 51 , wherein the damaged region is ischemic.

53 . The method of claim 51 , wherein said attaching comprises attaching the stromal tissue to the damaged region by means of a biodegradable or non-biodegradable suture, a biologic glue, a synthetic glue, a laser dye, or a hydrogel.

Assignments (4)
MERGER Recorded Jan 25, 2012
From: THEREGEN, INC., A CALIFORNIA CORPORATION
To: THEREGEN, INC., A DELAWARE CORPORATION
Reel/Frame 027590/0948 →
CHANGE OF NAME Recorded Jan 23, 2012
From: IKEN TISSUE THERAPEUTICS
To: THEREGEN, INC.
Reel/Frame 027578/0706 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2012
From: ATS LIQUIDATING TRUST
To: IKEN TISSUE THERAPEUTICS
Reel/Frame 027563/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2012
From: NAUGHTON, GAIL K.; MANSBRIDGE, JONATHAN N.; PINNEY, ROBERT E.; ZELTINGER, JOAN
To: ADVANCED TISSUE SCIENCES, INC.
Reel/Frame 027545/0811 →